Cost-analysis of four treatment strategies in the management of moderate-to-severe COPD: An application of non-parametric bootstrap;Analisi dei costi di quattro strategie terapeutiche nella gestione di pazienti con broncopneumopatia (BPCO) moderata o severa: Un' applicazione del metodo bootstrap

PharmacoEconomics - Italian Research Articles

Volumn 7, Issue 2, 2005, Pages 135-143

  Fattore, Giovanni ^a,b,d   Torbica, A ^a   Mangone, M ^c  

^a BOCCONI UNIVERSITY   (Italy)

^b UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^c ASTRAZENECA   (United Kingdom)

^d CeRGAS SDA Univ L Bocconi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; FORMOTEROL; PLACEBO;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; HEALTH CARE COST; HUMAN; ITALY; NATIONAL HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL;

EID: 22644440346     PISSN: 15909158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03320543     Document Type: Article

References (12)

1. Lucioni C, Donner C, De Benedetto F, et al. I costi della broncopneumatopia cronica ostruttiva in Italia. Presentazione della prima fase dello studio ICE (Italian Costs for Exacerbations in COPD). Pharmacoeconomics- Italian Research Articles 2004; 6: 5-14
2. Pauwels R, Rabe K. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-20
3. Wouters EFM. Economic analysis of the Confronting COPD survey: an overview of results. Respir Med 2003; 97 (Suppl. C): S3-14
4. Dal Negro R, Rossi A, Cerveri I. The burden of COPD in Italy: results from the Confronting COPD survey. Respir Med 2003; 97(Suppl. C): S43-50
5. Motterlini N, Koleva D, Garattini L. I costi della BPCO in Italia: l'analisi retrospettiva dello studio BIC. Economia e Politica del Farmaco 2005; 4: 20-8
6. Ministero della Salute. Statistiche sui ricoveri ospedalieri www.ministerosalute.it, visitato il 30/06/2004
7. Szafranski W, Cukier A, Ramirez A, et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Resp J 2003; 21: 74-81
8. Calverley PM, Boonsawat W, Cseke Z, et al. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 2003; 22: 912-9
9. Koopmanschap M, Touw K, Rutten F. Analysis of costs and cost-effectiveness in multinational trials. Health Policy 2001; 58: 175-86
10. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000; 19: 3219-36
11. O'Hagan A, Stevens JW. Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? Health Econ 2003; 12: 33-49
12. Desgagne A, Castilloux AM, Angers JF, LeLorier J. The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics 1998; 13: 487-97